NEJMÊÙ¶¯²ñ2003 Âè1²ó03/01/22 ¼Â»Ü A¥×¥ê¥ó¥È ôÅö: ¿¹Àî ¿¿Âç (morikawa-tky@umin.ac.jp)
Case 26-2002:
An 87-Year-Old Woman with Abdominal Pain, Vomiting, Bloody Diarrhea, and an Abdominal Mass
¡ÊVolume 347(8): 601-606¡Ë
¨¡¨¡¨¡Ê¢ÄË¡¤ÓÒÅÇ¡¤·ìÀ­¤Î²¼Î¡¡¤Ê¢Éô¼ðáǧ¤á¤é¤ì¤¿87ºÐ½÷À­¨¡¨¡¨¡

¡Ú´µ¼Ô¡Û 87ºÐ½÷À­
¡Ú¼çÁʡ۠ʢÄË¡¤ÓÒÅÇ¡¤²¼·ì¡¤Ê¢Éô¼ðáî
¡Ú¸½ÉÂÎò¡Û
  È¯¾ÉÁ°¤Þ¤Ç¡¤´µ¼Ô¤Î·ò¹¯¾õÂ֤ϰÂÄꤷ¤Æ¤¤¤¿¡¥
  Æþ±¡¤Î2ÆüÁ°¤«¤é¡¤±Ô¤¯¼¡Âè¤ËÁý¶¯¤¹¤ë²¼Ê¢ÉôÄˤ¬½Ð¸½¤·¤¿¡¥°­¿´¡¤ÓÒÅÇ¡¤»þ¡¹Á¯·ì¤òǧ¤á¤ë²¼Î¡¤òȼ¤¤¡¤°ÊÍè¿©»ö¤ò¤È¤ë¤³¤È¤¬¤Ç¤­¤Ê¤«¤Ã¤¿¡¥´µ¼Ô¤ÏMGH¤ËÆþ±¡¤·¤¿¡¥¸½ºß¤Þ¤ÇÅÇ·ì(-)¡¤È¯Ç®(-)¡¤¶»ÄË(-)¡¤¸ÆµÛº¤Æñ(-)¡¤Éâ¼ð(-)¡¥
¡Ú´û±ýÎò¡Û
¿Ò¾ïÀ­Å·á×áì(¾ÜºÙÉÔÌÀ¡¤¸½ºß¤Ï´²²ò¤È¤Î¤³¤È)¡¤¿´Ë¼ºÙÆ°(81ºÐ¡¤ÉþÌôÃæ)¡¤ÎÐÆâ¾ã(ÅÀ´ãÃæ)¡¤¿Í¹©É¨´ØÀáÁ´ÃÖ´¹½Ñ¡¤±¦À¼ÂÓËãáã(TKR ope»þ¤ÎÁ޴ɸ夫¤é)
¡ÚÀ¸³èÎò¡Û alcohol (-), cigarettes (-)
¡ÚÉþÌôÎò¡Û digoxin¡¤warfarin¡¤hydrochlorothiazide¡¤metoprolol¡¤betaxolol (ÅÀ´ã)¡¤prednisone (ÅÀ´ã)¡¤brimonidine (ÅÀ´ã)
¡ÚÆþ±¡»þ¸½¾É¡Û
<VITAL SIGNS> BT 36.9 ¡î, BP 150/70 mmHg, PR 88 /min irreg., RR 20 /min, SpO2 96 %(room air)
<NECK> jugular venous pulse: 4 cm above sternal notch
<LUNG> lung sound: clear
<HEART> apical systolic murmur (Levine ­µ/­º), aortic diastolic murmur (Levine ­¶/­º)
<ABDOMEN> distended, bowel sounds: present, slightly tender mass (15-20 cm) in the right lower quadrant, hernia (-)
<EXTREMITIES> well perfused, edema (-), clubbing (-)
<RECTAL EXAMINATION> n.p.
¡ÚÆþ±¡»þ¸¡ºº½ê¸«¡Û(Table 1¤ÈTable 2¤ò»²¾È)
<CBC> WBC 11.1¡ß103/mm3 (Neu 80 %, Eos 1 %, Baso 1 %, Mono 5%, Lym 13 %), Ht 40.6%, Plt 27.3¡ß104/mm3
<CHEMISTRY> TP, Alb, AST(GOT), ALT(GPT), ALP, T. Bil, D. Bil, BUN, Cre, electlytes, Ca, iP, Glu, UA, AMY, LIP, Troponin I(TnI): w.n.l.
<COAGULATION> PT 22.0 sec., PTT 37.9 sec., ESR 16 mm/hr
<U/A> n.p.
<FECAL OCCULT BLOOD> (-)
<DRUGS> digoxin 1.2 ng/ml
<ECG> HR 63, Af, non-specific ST-segment and T-wave abnormalities & prominent R (V2)
<CXR> lung fields: clear, heart: n.p.
<Ê¢Éô¡¦¹üÈפ±ÆCT> (Fig. 1¤ÈFig. 2¤ò»²¾È)
  Â¤±ÆºÞ¤Ï·Ð¸ýŪ¤È·ÐÀÅ̮Ū¤ËÅêÍ¿¤µ¤ì¤¿¡¥10¡ß6 cmÂç¤ÎÉԶѰì¤Ê¼ðáÌÕIJ¤«¤é¾å¹Ô·ëIJ¶á°ÌÉô¤ÎÆâ¹Ð¤òËþ¤¿¤·¤Æ¤¤¤¿¡¥¼ðáî¤ÎÊÕ±ï¤ÏÉÔÀ°¤Ç¥·¥À¾õ(frond-like)¤Ç¤¢¤Ã¤¿¡¥¾®Ä²¤Ë¤ÏËÄËþ¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡¥Â¤±ÆºÞ¤Ï¼ðáîÉôʬ¤òÄ̲ᤷ²£¹Ô·ëIJ¤Þ¤ÇÅþ㤷¤Æ¤¤¤¿¡¥S¾õ·ëIJ¤Ë·Æ¼¼¤¬Â¿È¯¤·¤Æ¤¤¤¿¤¬¡¤·Æ¼¼±ê¤ò¼¨¤¹½ê¸«¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡¥
<99mTc-sestamibi scintigraphy>
  ±¿Æ°Éé²Ù»þ¤Î¿´¶Ú¥·¥ó¥Á¥°¥é¥Õ¥£¡¼¤ò»Ü¹Ô¤·¤¿¤¬¡¤Æõ­¤¹¤Ù¤­½ê¸«¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡¥
 
¡ÚÆþ±¡¸å·Ð²á¡Û
  Æþ±¡¸å¤Ïwarfarin¤ò°ìöÃæ»ß¤·¡¤cefotetan¡¤metronidazole¡¤cefazolin¡¤vitamin K¡¤FFP¤ò³«»Ï¤·¤¿¡¥digoxin¡¤metoprolol¡¤ÅÀ´ãÌô¤Ï·Ñ³¤µ¤ì¤¿¡¥Ê¢ÄˤÏǧ¤á¤é¤ì¤¿¤¬¡¤acetaminophen¤Î¤ß¤Ç¼õÍƲÄǽ¤Ç¤¢¤Ã¤¿¡¥¤Þ¤¿¡¤Ê¢Éô¡¦¹üÈפ±ÆCT¤¬»Ü¹Ô¤µ¤ì¤¿(Fig. 1¡¤Fig. 2)¡¥
 
  ¤¢¤ë¿ÇÃÇŪ¼êµ»¤¬»Ü¹Ô¤µ¤ì¤¿¡¥